Orbimed Advisors Llc Compass Therapeutics, Inc. (CMPX) insider trading activity
Orbimed Advisors LLC is Director of Compass Therapeutics, Inc.. Currently has a direct ownership of 12.7 Million shares of CMPX, which is worth approximately $20.9 Million. The most recent transaction as insider was on Jun 19, 2020, when has been sold 1,455,132 shares (Common Stock) at a price of $5.0 per share, resulting in proceeds of $7,275,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.7M
0%
3M change
0%
12M change
Total Value Held
$20.9 Million
ORBIMED ADVISORS LLC Transaction History
Also insider at
OAL
Orbimed Advisors LLC
Director
San Diego, CA